KETEK

LOE Approaching

telithromycin

NDAORALTABLET
Approved
Apr 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
18

Clinical Trials (5)

NCT00315042Phase 3Terminated

TELI TON - Telithromycin in Tonsillitis

Started Mar 2006
314 enrolled
TonsillitisPharyngitis
NCT00315549Phase 3Terminated

TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults

Started Feb 2006
233 enrolled
TonsillitisPharyngitis
NCT00288223Phase 4Terminated

Telithromycin in Acute Exacerbation of Chronic Bronchitis

Started Jan 2006
54 enrolled
Bronchitis, Chronic
NCT00315003Phase 3Terminated

TELI COM - Telithromycin in Children With Otitis Media

Started Jan 2006
1,500 enrolled
Otitis Media, SuppurativeOtitis Media, Purulent
NCT00237445Phase 4Terminated

Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days

Started Nov 2005
110 enrolled
Pneumonia